Oxeladin CitrateCAS# 52432-72-1 |
- Daptomycin
Catalog No.:BCC1057
CAS No.:103060-53-3
- Nelarabine
Catalog No.:BCC1072
CAS No.:121032-29-9
- Gemcitabine HCl
Catalog No.:BCC1076
CAS No.:122111-03-9
- Clofarabine
Catalog No.:BCC1078
CAS No.:123318-82-1
- Ifosfamide
Catalog No.:BCC1164
CAS No.:3778-73-2
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 52432-72-1 | SDF | Download SDF |
PubChem ID | 9936727 | Appearance | Powder |
Formula | C26H41NO10 | M.Wt | 527.6 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 100 mg/mL (189.54 mM) H2O : ≥ 50 mg/mL (94.77 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 2-[2-(diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate;2-hydroxypropane-1,2,3-tricarboxylic acid | ||
SMILES | CCC(CC)(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O | ||
Standard InChIKey | KVKJFNUGVOFNGU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H33NO3.C6H8O7/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4;7-3(8)1-6(13,5(11)12)2-4(9)10/h9-13H,5-8,14-17H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Oxeladin citrate is a cough suppressant, is a highly potent and effective drug used to treat all types of cough of various etiologies. |
Oxeladin Citrate Dilution Calculator
Oxeladin Citrate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.8954 mL | 9.4769 mL | 18.9538 mL | 37.9075 mL | 47.3844 mL |
5 mM | 0.3791 mL | 1.8954 mL | 3.7908 mL | 7.5815 mL | 9.4769 mL |
10 mM | 0.1895 mL | 0.9477 mL | 1.8954 mL | 3.7908 mL | 4.7384 mL |
50 mM | 0.0379 mL | 0.1895 mL | 0.3791 mL | 0.7582 mL | 0.9477 mL |
100 mM | 0.019 mL | 0.0948 mL | 0.1895 mL | 0.3791 mL | 0.4738 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Oxeladin Citrate
- Cochlearine
Catalog No.:BCN1929
CAS No.:52418-07-2
- Boc-D-Met-OH
Catalog No.:BCC3426
CAS No.:5241-66-7
- Boc-D-Trp-OH
Catalog No.:BCC3457
CAS No.:5241-64-5
- H-Phe-NH2
Catalog No.:BCC3008
CAS No.:5241-58-7
- (R)-DPN
Catalog No.:BCC7939
CAS No.:524047-78-7
- Noricaritin
Catalog No.:BCN5353
CAS No.:5240-95-9
- 2-APB
Catalog No.:BCC6978
CAS No.:524-95-8
- Fraxin
Catalog No.:BCN1237
CAS No.:524-30-1
- Dauricine
Catalog No.:BCN4977
CAS No.:524-17-4
- gamma-Fagarine
Catalog No.:BCN5673
CAS No.:524-15-2
- Wedelolactone
Catalog No.:BCN5672
CAS No.:524-12-9
- Epistephamiersine
Catalog No.:BCN5671
CAS No.:52389-15-8
- Isobutylshikonin
Catalog No.:BCN3005
CAS No.:52438-12-7
- 1-Cinnamoylpyrrolidine
Catalog No.:BCN4086
CAS No.:52438-21-8
- ERB 041
Catalog No.:BCC7903
CAS No.:524684-52-4
- Vandetanib hydrochloride
Catalog No.:BCC2028
CAS No.:524722-52-9
- Isokurarinone
Catalog No.:BCN2890
CAS No.:52483-02-0
- 5-(Z-heptadec-8-enyl) resorcinol
Catalog No.:BCN5674
CAS No.:52483-19-9
- D-Tryptophanol
Catalog No.:BCC2699
CAS No.:52485-52-6
- Peonidin-3-O-arabinoside chloride
Catalog No.:BCN3029
CAS No.:524943-91-7
- PSB 36
Catalog No.:BCC7240
CAS No.:524944-72-7
- Dihydrokainic acid
Catalog No.:BCC6556
CAS No.:52497-36-6
- Fraxidin
Catalog No.:BCN5675
CAS No.:525-21-3
- Harmalol
Catalog No.:BCC8183
CAS No.:525-57-5
High performance liquid chromatographic determination of oxeladin citrate and oxybutynin hydrochloride and their degradation products.[Pubmed:16023117]
Farmaco. 2005 Aug;60(8):689-99.
Two high performance liquid chromatographic (HPLC) methods are presented for the determination of Oxeladin Citrate (OL) and oxybutynin hydrochloride (OB) and their degradation products. The first method was based on HPLC separation of OL from its degradation product using a Nucleosil C(18) column with a mobile phase consisting of acetonitrile -0.1% phosphoric acid (60:40 v/v). The second method was based on HPLC separation of OB from its degradation product using a VP-ODS C(18) column with a mobile phase consisting of acetonitrile/0.01 M potassium dihydrogen phosphate/diethylamine (60:40:0.2). Quantitation was achieved with UV detection at 220 nm based on peak area. The two HPLC methods were applied for the determination of OL or OB, their degradation products, methylparaben and propylparaben in pharmaceutical preparations. The proposed methods were used to investigate the kinetics of acidic and alkaline degradation processes of OL and OB at different temperatures and the apparent pseudofirst-order rate constant, half-life and activation energy were calculated. The pH-rate profiles of degradation of OL and OB in Britton-Robinson buffer solutions within the pH range 2-12 were studied.